ArticleBioengineered2022

Overcoming chemoresistance to b-raf inhibitor in melanoma via targeted inhibition of phosphoenolpyruvate carboxykinase1 using 3-mercaptopropionic acid.

Ming Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.